Matthias Eiber

Also affiliated with Heidelberg University, TUM Klinikum, Klinik und Poliklinik für Nuklearmedizin, German Center for Infection Research, Comprehensive Cancer Center Erlangen, Nuklearmedizinische Klinik des Klinikums rechts der Isar, Deutsches Konsortium für Translationale Krebsforschung, Technical University of Munich

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls”.

Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls

RadioGraphics(2018)10.1148/rg.2018170108

N/A

0.892DataRank · unranked

382 citations

Rodney J. Hicks, Tobias Maurer, Matthias Eiber, Michael S. Hofman

Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

Annals of Oncology(2025)10.1016/j.annonc.2025.07.003

N/A

0.663DataRank · unranked

31 citations

K.N. Chi, Neal D. Shore, Ken Herrmann, Johann S. De Bono, Daniel Castellano +88 more

Prostate-specific Membrane Antigen–radioguided Surgery Facilitates Pelvic Lymph Node Dissection During Radical Prostatectomy for the Treatment of Locally Advanced Prostate Cancer with Regional Lymph Node Metastases

European Urology Oncology(2023)10.1016/j.euo.2022.12.001

N/A

0.434DataRank · unranked

17 citations

Lisa Steinhelfer, Philipp Korn, Matthias Eiber, Tobias Maurer, Jakob Büchler +4 more

The role of non-FDG agents in PET imaging of bladder cancer

Seminars in Nuclear Medicine(2026)10.1053/j.semnuclmed.2025.11.013

N/A

0.104DataRank · unranked

1 citations

Dina Muin, Lena Unterrainer, Anton Hörmann, Francesco Mattana, Valentino Dragonetti +5 more

Prostate-specific Membrane Antigen Reporting and Data System Version 2.0

European Urology(2023)10.1016/j.eururo.2023.06.008

N/A

0DataRank · unranked

67 citations

Philipp E. Hartrampf, Wolfgang P. Fendler, Sebastian E. Serfling, Thorsten Derlin, Takahiro Higuchi +8 more

Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial

Journal of Nuclear Medicine(2020)10.2967/jnumed.120.242180

N/A

0DataRank · unranked

117 citations

Justin Ferdinandus, Johannes Czernin, Matthias Eiber, Robert R. Flavell, Spencer C. Behr +13 more

Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)

Journal of Nuclear Medicine(2021)10.2967/jnumed.121.262543

N/A

0DataRank · unranked

37 citations

Johannes Czernin, Pan Thin, J Gartmann, Kathleen Nguyen, Wesley R. Armstrong +14 more